Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Assmann

Showing results (21-30 of 495) with videos related to

Pageof 50
Sort By:
Drugs|January 1, 1990
Primary prevention of coronary heart disease in the Federal Republic of Germany. Analysis of cost-effectivenessG Assmann, H Schulte
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 28, 2000
Primary prevention of coronary heart disease: from controversy to consensusP Cullen, G Assmann
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 10, 2001
The role of PPAR alpha in obesityU Seedorf, G Assmann
The American Journal of Cardiology|December 5, 1997
Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: absolute levels or extent of lowering?P Cullen, G Assmann
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|January 1, 1981
[Performance and limitations of the analysis of HDL-cholesterol (author's transl)]G Assmann, H Schriewer
Best Practice & Research. Clinical Rheumatology|November 22, 2011
The SAPHO syndrome--are microbes involved?G Assmann, P Simon
Klinische Wochenschrift|August 1, 1980
[HDL cholesterol: biochemical aspects (author's transl)]G Assmann, H Schriewer
The American Journal of Cardiology|May 2, 1989
Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease riskG Assmann, H Schulte
The American Journal of Cardiology|May 2, 1989
European lipid guidelines: therapeutic recommendations. European Atherosclerosis SocietyG Assmann, H Schulte
The American Journal of Cardiology|December 14, 1992
Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster StudyG Assmann, H Schulte
Pageof 50

Showing results (21-30 of 495) with videos related to

Sort By:
Pageof 50
Drugs|January 1, 1990
Primary prevention of coronary heart disease in the Federal Republic of Germany. Analysis of cost-effectivenessG Assmann, H Schulte
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 28, 2000
Primary prevention of coronary heart disease: from controversy to consensusP Cullen, G Assmann
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 10, 2001
The role of PPAR alpha in obesityU Seedorf, G Assmann
The American Journal of Cardiology|December 5, 1997
Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: absolute levels or extent of lowering?P Cullen, G Assmann
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|January 1, 1981
[Performance and limitations of the analysis of HDL-cholesterol (author's transl)]G Assmann, H Schriewer
Best Practice & Research. Clinical Rheumatology|November 22, 2011
The SAPHO syndrome--are microbes involved?G Assmann, P Simon
Klinische Wochenschrift|August 1, 1980
[HDL cholesterol: biochemical aspects (author's transl)]G Assmann, H Schriewer
The American Journal of Cardiology|May 2, 1989
Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease riskG Assmann, H Schulte
The American Journal of Cardiology|May 2, 1989
European lipid guidelines: therapeutic recommendations. European Atherosclerosis SocietyG Assmann, H Schulte
The American Journal of Cardiology|December 14, 1992
Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster StudyG Assmann, H Schulte
Pageof 50